1.Spinal cord stimulation for spinal cord injury from 1999 to 2025: a bibliometric analysis
Yuanyuan QI ; Haifeng GAO ; Lina LIU ; Yujie XIE ; Jing XU ; Feng GAO ; Liang CHEN ; Degang YANG ; Jun LI
Chinese Journal of Rehabilitation Theory and Practice 2026;32(4):373-386
ObjectiveTo analyze the research hotspots and development trends in the field of spinal cord stimulation (SCS) for spinal cord injury (SCI). MethodsLiterature about SCS for SCI was retrieve from the Web of Science (WOS) Core Collection database, with a time range from January, 1999 to July, 2025. VOSviewer 1.6.20 and CiteSpace 6.4.R2 were used to analyze the annual publication volume, countries, authors, institutions, journals and keywords. ResultsA total of 636 literatures were included. From 1999 to 2025, the overall publication trend in this field showed an upward trajectory, with recent years fluctuating but tending to stabilize. The country with the most publications was the United States (429 papers), followed by Russia (98 papers) and China (70 papers). The institution with the highest number of publications was the University of California, Los Angeles (76 papers), the author with the most publications was V. Reggie Edgerton (70 papers), and the journal with the most publications was Journal of Clinical Medicine (31 papers). The most frequently cited study focused on exploring the combination of epidural spinal cord stimulation with task-specific training to restore motor function in patients with complete SCI. Keyword analysis showed that the research hotspots in this field were mainly focused on neuroregulation mechanisms, recovery of motor and autonomic nervous dysfunction, artificial intelligence, closed-loop stimulation and brain-computer interface technology innovations. In recent years, the research focus gradually shifted from basic mechanisms to personalized and precise multifunctional rehabilitation strategies. ConclusionThe field of SCS for SCI has undergone phases of basic mechanism exploration and clinical application expansion. Current research hotspots and future trends focus primarily on the development of new stimulation paradigms and combined innovative technologies.
2.Effect of cluster scalp acupuncture combined with Taijiquan on brain functional connectivity and network topology for patients with post-stroke depression
Yujie GUAN ; Keyan LIU ; Keqin YANG ; Yulin LIANG ; Jinpeng ZHANG ; Bin ZHAO
Chinese Journal of Rehabilitation Theory and Practice 2026;32(6):621-630
ObjectiveTo explore the effect of cluster scalp acupuncture combined with Taijiquan training on depressive symptom, motor function, activities of daily living, serum markers, as well as brain functional connectivity (FC) and network topological properties in patients with post-stroke depression (PSD). MethodsA total of 40 PSD patients in the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine from September, 2022 to September, 2023 were enrolled and randomly divided into control group (n = 20) and experimental group (n = 20). The control group received cluster scalp acupuncture alone, while the experimental group underwent Taijiquan training in addition, for four weeks. They were assessed with Hamilton Depression Scale-17 (HAMD-17), Fugl-Meyer Assessment (FMA) and Barthel Index (BI) before and after treatment, while the serum levels of dopamine (DA), 5-hydroxytryptamine (5-HT), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were detected with enzyme-linked immunosorbent assay. Resting-state functional magnetic resonance imaging (rs-fMRI) was applied to assess brain FC, as well as the global efficiency (Eg) and small-world property (σ) of brain networks. ResultsThe scores of HAMD-17, FMA and BI improved in both groups (t > 2.922, P < 0.01) after treatment, and improved more in the experimental group than in the control group (t > 2.517, P < 0.05). The serum levels of DA and 5-HT increased in both groups (t > 2.637, P < 0.05), and increased more in the experimental group (t > 2.192, P < 0.05). The serum levels of IL-6 and TNF-α decreased in the experimental group after treatment (t > 4.059, P < 0.001), and they were less than those in the control group (t > 2.154, P < 0.05). FC between left middle frontal gyrus and right anterior cingulate gyrus, as well as between left hippocampus and right precuneus were higher in the experimental group than in the control group after treatment (t > 3.867, P < 0.001), while Eg and σ increased in both groups (t > 2.828, P < 0.05), and they were higher in the experimental group (t > 2.675, P < 0.05). ConclusionCombination of Taijiquan training is more effective on depressive symptoms, motor function and activities of daily living in PSD patients, which may be related to up-regulation of serum DA and 5-HT, reduction of inflammatory factors, enhancement of prefrontal-limbic system functional connectivity and optimization of brain network topological properties.
3.Comparative analysis of centrifugal and membrane double plasma molecular adsorption systems combined with low-dose plasma exchange in the treatment of liver failure
Yan HU ; Bangqiang ZHU ; Haijing WANG ; Peng YANG ; Wei XU ; Maohong BIAN ; Junfei ZHANG ; Zhen DA ; Yujie DIAO
Chinese Journal of Blood Transfusion 2026;39(7):859-866
Objective: To investigate the efficacy and safety of centrifugal and membrane double plasma molecular adsorption systems (DPMAS) combined with low-dose plasma exchange in the treatment of liver failure. Methods: A retrospective analysis was performed on 60 patients with liver failure treated in our hospital from April 2024 to June 2025. Based on different plasma separation methods, they were divided into the centrifugal DPMAS group (n=30) and the conventional membrane DPMAS group (n=30). The operational parameters, laboratory indicators, and adverse reactions were compared between the two groups. Results: Under the same plasma volume for adsorption and exchange (P>0.05), the centrifugal group showed lower total circulating blood volume, total blood flow rate, and treatment duration compared to the membrane group [10 794 (9 532, 12 637) vs 19 000 (19 000, 21 000) mL, 60 (60, 65) vs 125 (120, 130) mL/min, 169 (141, 193) vs 207 (183, 210) min, P<0.001]. The centrifugal group also had a lower rate of central venous catheter use [(24/30, 80.00%) vs (30/30, 100.00%), P=0.024] and required more calcium supplementation due to sodium citrate anticoagulation [6 (6, 8) vs 2 (2, 2) g, P<0.001]. No significant changes were observed in WBC, Hb, HCT, and PLT levels before and after treatment with the centrifugal group (P>0.05). There was no statistically significant difference in WBC levels before and after membrane group treatment (P=0.199), but the values of Hb, HCT, and PLT showed significant decreases post-treatment compared to pre-treatment [106.50 (102.75, 126.75) vs 123.00 (109.75, 132.00) g/L, 33.20 (29.90, 34.92) vs 34.85 (31.55, 37.52)%, 85.00 (43.25, 139.50) vs 93.00 (61.50, 145.00)×10
/L, P<0.05]. There was no significant difference in coagulation function indexes before and after treatment with centrifugal group (P>0.05). The membrane group showed reduction in fibrinogen (Fib) levels post-treatment [1.50 (1.20, 1.60) vs 1.60 (1.25, 1.80) g/L, P=0.033]. Both groups demonstrated significant decreases in total bilirubin (TBil) and direct bilirubin (DBil) levels after treatment (centrifugal group: 194.70 (107.50, 276.00) vs 239.15 (173.00, 304.17) μmol/L, 101.00 (64.00, 182.30) vs 157.00 (101.00, 195.00) μmol/L; membrane group: 211.50 (118.00, 240.00) vs 263.50 (204.75, 314.00) μmol/L, 188.00 (122.75, 232.25) vs 219.00 (178.50, 267.25) μmol/L, P<0.05]. The incidence of catheter-related complications was lower in the centrifugal group [(2/30, 6.67%) vs (8/30, 26.67%), P=0.038]. Conclusion: The centrifugal DPMAS system demonstrates advantages such as lower blood flow velocity requirements, shorter treatment duration, minimal impact on platelets, and reduced adverse event rates, indicating promising clinical applications.
4.Exploring Pathogenesis and Treatment of Gastric Cancer Metastasis Based on Blood Harmonizing Method
Zhongbo ZHU ; Wenying YANG ; Fangni LI ; Yujie YANG ; Jungang DONG ; Xiping LIU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(20):63-73
Metastasis in gastric cancer is a key factor contributing to poor prognosis. Its pathogenesis is complex, characterized by a combination of underlying deficiency and superficial excess, cold and heat in complexity, and stagnation in collateral Conventional aggressive treatment methods tend to exacerbate the depletion of healthy Qi and Zang-Fu organ dysfunctions. The harmonizing method in traditional Chinese medicine (TCM) emphasizes holistic regulation and reinforcing healthy Qi while expelling pathogenic factors. The blood harmonizing method is grounded in the core TCM theory of blood vessel transmission and Zang-Fu organ accumulation of cancerous toxins. It closely addresses the essence of metastasis-where cancerous toxins spread through the bloodstream and accumulate in the collaterals-thereby providing a unique and feasible diagnostic and therapeutic approach for clinical intervention in gastric cancer metastasis. This paper systematically reviews relevant TCM theories such as transmission and Zang-Fu organ accumulation of cancerous toxins and accumulation-gathering and provides an in-depth explanation of the core pathogenesis of gastric cancer metastasis. Specifically, cancerous toxins circulate throughout the body via the blood vessels and accumulate in the collaterals of target organs such as the liver, peritoneum, lymph nodes, and lungs. The occurrence and development of this process are consistently centered on the key mechanism of disharmony in blood-related syndromes. On this basis, the paper explicitly proposes three major therapeutic approaches centered on harmonizing the blood. The first is harmonizing the blood to restore ascending and descending functions, thereby invigorating the spleen and regulating the middle energizer to restore the mediating function of the middle energizer and block the generation of phlegm and blood stasis at the root. The second is harmonizing the blood to balance cold and heat, using pungent herbs to open and bitter herbs to descend to harmonize the Yin-Yang balance and improve the homeostasis of the tumor microenvironment. The third is harmonizing the blood to unblock collaterals and resolve stasis, thereby gradually dissipating stasis and nodules, gently clearing obstructions in the collaterals, and breaking the critical link of collateral stagnation forming masses caused by metastasis. The article further summarizes modern pharmacological research findings on representative formulas such as Banxia Xiexintang, Weichang'an, Yangzheng Sanjie decoction, and Sijunzitang, confirming that they can inhibit the proliferation, invasion, and metastasis of gastric cancer cells, as well as epithelial-mesenchymal transition, through multiple targets and pathways, to regulate angiogenesis and lymphangiogenesis, modulate the immune microenvironment, and induce tumor cell apoptosis and ferroptosis, thereby blocking the metastasis process at multiple levels. This paper discusses the theoretical basis, pathogenetic mechanisms, therapeutic systems, and modern mechanisms of the blood harmonizing method for the diagnosis and treatment of gastric cancer metastasis. It fully embodies the TCM principles of targeting balance, reinforcing healthy Qi without aiding the pathogen, and eliminating the pathogen without harming the healthy Qi, providing a solid theoretical foundation and practical pharmacological references for the prevention and treatment of gastric cancer metastasis with integrated traditional Chinese and Western medicine in clinical practice.
5.Exploring Pathogenesis and Treatment of Gastric Cancer Metastasis Based on Blood Harmonizing Method
Zhongbo ZHU ; Wenying YANG ; Fangni LI ; Yujie YANG ; Jungang DONG ; Xiping LIU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(20):63-73
Metastasis in gastric cancer is a key factor contributing to poor prognosis. Its pathogenesis is complex, characterized by a combination of underlying deficiency and superficial excess, cold and heat in complexity, and stagnation in collateral Conventional aggressive treatment methods tend to exacerbate the depletion of healthy Qi and Zang-Fu organ dysfunctions. The harmonizing method in traditional Chinese medicine (TCM) emphasizes holistic regulation and reinforcing healthy Qi while expelling pathogenic factors. The blood harmonizing method is grounded in the core TCM theory of blood vessel transmission and Zang-Fu organ accumulation of cancerous toxins. It closely addresses the essence of metastasis-where cancerous toxins spread through the bloodstream and accumulate in the collaterals-thereby providing a unique and feasible diagnostic and therapeutic approach for clinical intervention in gastric cancer metastasis. This paper systematically reviews relevant TCM theories such as transmission and Zang-Fu organ accumulation of cancerous toxins and accumulation-gathering and provides an in-depth explanation of the core pathogenesis of gastric cancer metastasis. Specifically, cancerous toxins circulate throughout the body via the blood vessels and accumulate in the collaterals of target organs such as the liver, peritoneum, lymph nodes, and lungs. The occurrence and development of this process are consistently centered on the key mechanism of disharmony in blood-related syndromes. On this basis, the paper explicitly proposes three major therapeutic approaches centered on harmonizing the blood. The first is harmonizing the blood to restore ascending and descending functions, thereby invigorating the spleen and regulating the middle energizer to restore the mediating function of the middle energizer and block the generation of phlegm and blood stasis at the root. The second is harmonizing the blood to balance cold and heat, using pungent herbs to open and bitter herbs to descend to harmonize the Yin-Yang balance and improve the homeostasis of the tumor microenvironment. The third is harmonizing the blood to unblock collaterals and resolve stasis, thereby gradually dissipating stasis and nodules, gently clearing obstructions in the collaterals, and breaking the critical link of collateral stagnation forming masses caused by metastasis. The article further summarizes modern pharmacological research findings on representative formulas such as Banxia Xiexintang, Weichang'an, Yangzheng Sanjie decoction, and Sijunzitang, confirming that they can inhibit the proliferation, invasion, and metastasis of gastric cancer cells, as well as epithelial-mesenchymal transition, through multiple targets and pathways, to regulate angiogenesis and lymphangiogenesis, modulate the immune microenvironment, and induce tumor cell apoptosis and ferroptosis, thereby blocking the metastasis process at multiple levels. This paper discusses the theoretical basis, pathogenetic mechanisms, therapeutic systems, and modern mechanisms of the blood harmonizing method for the diagnosis and treatment of gastric cancer metastasis. It fully embodies the TCM principles of targeting balance, reinforcing healthy Qi without aiding the pathogen, and eliminating the pathogen without harming the healthy Qi, providing a solid theoretical foundation and practical pharmacological references for the prevention and treatment of gastric cancer metastasis with integrated traditional Chinese and Western medicine in clinical practice.
6.Still′s Disease: From Unified Disease Nomenclature to Updated Treatment Strategies
Qiongyi HU ; Yujie SHEN ; Chengde YANG
JOURNAL OF RARE DISEASES 2026;5(3):269-273
Still′s disease is a classic autoinflammatory disease, predominantly manifested by polyarthritis and systemic inflammation, with severe complications including macrophage activation syndrome and pulmonary disease. In 2024, the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society for the first time defined systemic juvenile idiopathic arthritis and adult-onset Still′s disease collectively as a single disease entity, that is, Still′s disease. This review summarizes the unification of disease nomenclature for Still′s disease, advances in pathogenesis research, updates in therapeutic regimens, and management strategies for difficult-to-treat patients, aiming to summarize cuttingedge evidence and provide references for the clinical diagnosis and treatment of this disease.
7.Hei Xiaoyaosan Reduces Neuroinflammation in APP/PS1 Mice via CX3CL1-CX3CR1 Signaling Axis
Yujie LYU ; Jiao YANG ; Yunyun HU ; Zhipeng MENG ; Yiqin CHEN ; Wenli PEI ; Yumei HAN ; Huping WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(22):83-90
ObjectiveTo investigate the effects of Hei Xiaoyaosan on neuroinflammation in APP/PS1 mice and decipher the mechanism based on the C-X3-C chemokine ligand 1 (CX3CL1)-CX3CL1 receptor 1 (CX3CR1) signaling axis. MethodsSixty 16-week-old male APP/PS1 mice were selected and acclimatized for one week, and they were then randomly allocated into a model group, a CX3CL1 group (bilateral hippocampal injection of CX3CL1 at 0.5 g·L-1), and high-, medium-, and low-dose (22.10, 11.05, and 5.53 g·kg-1, respectively) Hei Xiaoyaosan groups, with 12 mice in each group. Twelve age-matched male C57BL/6J mice served as the blank group (bilateral hippocampal injection of an equal volume of PBS). The high-, medium-, and low-dose Hei Xiaoyaosan groups received corresponding drugs via gavage, while the blank group received an equal volume of normal saline, with an intervention period of 90 days. Morris water maze was used to assess learning and memory abilities. Nissl staining was performed to observe the pathological changes in neurons of the hippocampal CA1 region. Immunohistochemistry was adopted to detect amyloid-β1-42 (Aβ1-42) deposition in the hippocampal CA1 region. The immunofluorescence assay was employed to detect the expression of M1 and M2 microglial markers, including cluster of differentiation 86 (CD86)/ionized calcium-binding adapter molecule 1 (Iba-1) and arginase-1 (Arg1)/Iba1. Enzyme-linked immunosorbent assay (ELISA) was employed to measure the levels of interleukin-8 (IL-8) and interleukin-13 (IL-13) in the hippocampal tissue. Western blot was employed to determine the protein levels of CX3CL1, CX3CR1, CREB-binding protein (CBP), cyclic AMP response element-binding protein (CREB), phosphorylated (p)-CREB, and brain-derived neurotrophic factor (BDNF) in the hippocampal tissue. ResultsCompared with the blank group, the model group exhibited prolonged escape latency on day 5 and a reduced swimming distance in the target quadrant (P<0.01), disarrangement of hippocampal neurons, with a reduced number of cells and uneven Nissl body staining, increased CD86/Iba1 expression, decreased Arg1/Iba1 expression (P<0.01), enhanced Aβ expression (P<0.01), an elevated IL-8 level and a declined IL-13 level (P<0.01), and downregulated protein levels of CX3CL1, CX3CR1, CBP, p-CREB, and BDNF (P<0.01). Compared with the model group, all treatment groups showed shortened escape latency on day 5 and an increased swimming distance in the target quadrant (P<0.05, P<0.01), regular arrangement of neurons with an increased number and increased Nissl bodies, reduced CD86/Iba1 expression, increased Arg1/Iba1 and decreased Aβ expression (P<0.01), and a declined IL-8 level and an elevated IL-13 level (P<0.05, P<0.01). In the CX3CL1 group and the high- and medium-dose Hei Xiaoyaosan groups, the relative expression levels of CX3CL1, CX3CR1, CBP, and p-CREB were upregulated (P<0.01). In the low-dose Hei Xiaoyaosan group, the relative expression levels of CX3CL1, CX3CR1, CBP, p-CREB/CREB, and BDNF were upregulated (P<0.05, P<0.01). ConclusionHei Xiaoyaosan can improve learning and cognitive abilities in APP/PS1 mice. Specifically, it may regulate the CX3CL1/CX3CR1 signaling axis to activate the CREB/BDNF signaling pathway for the subsequent release of BDNF, modulation of microglial polarization, reduction of inflammatory cytokine levels, and attenuation of Aβ deposition.
8.Mechanism analysis of Huangqi Guizhi Wuwu decoction in regulating nerve injury through vascular endothelial growth factor based on network pharmacology
Yinxiang WEN ; Yujie BI ; Dujun MA ; Lixin WANG ; Yuhao ZHOU ; Yuxin YANG
China Modern Doctor 2025;63(21):64-70
Objective To investigate the mechanism by which Huangqi Guizhi Wuwu decoction(HQGZWWD)regulates nerve injury(NI)through vascular endothelial growth factor(VEGF)pathway based on a combination of network pharmacology and molecular docking techniques.Methods Active ingredients and targets of HQGZWWD were identified through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform.A drug-ingredient-target network was constructed by integrated with data from OMIM,GeneCards,and CTD databases to identify VEGF/NI-related targets.Protein-protein interaction analyses were conducted by using STRING network platform,which were further analyzed by using the DAVID database for Gene Ontology/Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment.A"compound-target-pathway"network was constructed by using Cytoscape.Molecular docking was performed to validate the binding ability of core components with the targets.Results The primary constituents(quercetin,kaempferol)and principal targets[signal transducer and activator of transcription 3(STAT3),caspase 3,epidermal growth factor receptor(EGFR),etc.]of HQGZWWD were identified.KEGG analysis revealed that the targets were enriched cancer,EGFR inhibitor resistance,and advanced glycation end-products-receptor for advanced glycation end-products etc.signaling pathways.Molecular docking demonstrated binding energy between core components and STAT3,caspace 3,EGFR,etc.,specifically,the core components exhibited strong binding energy such as STAT3(≤-7.37kcal/mol).Conclusion HQGZWWD shows potency in suppressing inflammation,oxidative stress,and apoptosis,while promoting neural repair through VEGF regulation.The integration of network pharmacology and molecular docking offers a foundational framework for mechanistic investigations.
9.Effects of Yifei Jianpi Prescription on Airway Mucus Hypersecretion and Protein Expressions of EGFR/PKC/NF-κB Pathway in Rats with Acute Lung Injury
Yaru YANG ; Yujie YANG ; Zhongbo ZHU ; Xuhui ZHANG ; Xiping LIU ; Hongmei LI ; Shixia LI ; Shixin ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(9):83-90
Objective To observe the effects of Yifei Jianpi Prescription on airway mucus hypersecretion and protein expressions of EGFR/PKC/NF-κB pathway in lipopolysaccharide(LPS)-induced acute lung injury(ALI)model rats;To explore its mechanism in the treatment of ALI.Methods Ten of 60 SPF SD rats were randomly selected as blank group,and the other rats were intratracheal instilled with LPS to establish ALI model.The model rats were randomly divided into model group,dexamethasone group and Yifei Jianpi Prescription high-,medium-and low-dosage groups,with 8 rats in each group.Each treatment group was given corresponding drug solution by gavage,and the blank group and model group were given equal volume of normal saline by gavage,once a day for 14 days.The pulmonary functions of rats were measured[peak expiratory flow(PEF),tidal volume(TV),expiratory volume(EV),50%expiratory flow rate(EF50)],HE staining was used to observe the morphology of lung tissue,AB-PAS staining was used to evaluate the proliferation and mucus secretion of goblet cells,the expressions of epidermal growth factor receptor(EGFR),protein kinase C(PKC),nuclear factor-κB(NF-κB)p65 and MUC5AC in lung tissue were detected by immunofluorescence staining,the mRNA expressions of EGFR and MUC5AC in lung tissue were detected by fluorescent quantitative PCR,and the content of MUC5AC in lung tissue was detected by ELISA.Results Compared with the blank group,PEF,TV,EV and EF50 of the model group rats significantly decreased(P<0.01);the bronchial wall was significantly thickened,the lumen narrowed,pulmonary interstitial edema and hyperemia,the thickness of alveolar wall increased,accompanied by a large number of inflammatory cells infiltration,and the lung tissue injury score increased significantly(P<0.01);goblet cells proliferated significantly,mucus secretion increased significantly(P<0.01);the protein expressions of EGFR,PKC,NF-κB p65,MUC5AC and mRNA expressions of EGFR and MUC5AC in lung tissue increased significantly(P<0.01),and the content of MUC5AC in lung tissue increased significantly(P<0.01).Compared with the model group,PEF,TV,EV and EF50 in dexamethasone group and Yifei Jianpi Prescription each dosage groups increased in varying degrees;the pathological injury of lung tissue was alleviated to varying degrees,the score of lung tissue injury was reduced;the proliferation of goblet cells was reduced,and the secretion of mucus was reduced,the expressions of EGFR,PKC,NF-κB p65,MUC5AC protein and EGFR,MUC5AC mRNA in lung tissue decreased,and the content of MUC5AC in lung tissue decreased.There was statistical significance in dexamethasone group and Yifei Jianpi Prescription high-and medium-dosage groups(P<0.01).Conclusion Yifei Jianpi Prescription can inhibit the hypersecretion of airway mucus and the high expression of EGFR/PKC/NF-κB pathway protein in rats with ALI induced by LPS.
10.Research status of arsenic (organoarsenic) compounds applied in medicine
Hui LU ; Guangze YAO ; Yujie WEI ; Hui WANG ; Xinyang ZHAO ; Senlin ZHU ; Yiling LIU ; Qianlei YANG ; Yan AN
Chinese Journal of Endemiology 2025;44(3):253-258
Arsenic (organoarsenic) compound is one of the oldest drugs used by humans to treat various diseases. From its initial application in treating various skin diseases to the 1970s when arsenic trioxide (ATO) was proven to be able to significantly relieve acute promyelocytic leukemia (APL), arsenic (organoarsenic) compounds gradually occupied an important position in the history of medical development. This article reviews the pharmaceutical research progress of inorganic arsenic compounds and organic arsine compounds, covering anticancer, antiparasitic, antiviral and antibiotic aspects. It further explores the potential for developing new arsenic (organoarsenic) drugs with higher efficacy and lower toxicity, aiming to provide new research directions and ideas for the application of arsenic (organoarsenic) compounds in disease treatment.

Result Analysis
Print
Save
E-mail